Literature DB >> 16139856

Interaction of HIV-1 Gag with the clathrin-associated adaptor AP-2.

Melissa Batonick1, Manuel Favre, Michael Boge, Paul Spearman, Stefan Höning, Markus Thali.   

Abstract

The envelope glycoprotein (Env) of HIV-1 interacts with the clathrin-associated adaptor complex AP-2 during the late phase of the viral replication cycle. Upon its synthesis, Env, therefore, is retrieved from the cellular surface unless internalization is inhibited by viral Gag. Here we demonstrate that not only Env, but also HIV-1 Gag, specifically binds to AP-2. Gag-AP-2 association was found to depend on tyrosine residue 132 and valine residue 135 at the matrix-capsid junction in the Gag polyprotein. Results of a morphological analysis of viral egress from cells expressing dominant-negative AP-2 suggest an involvement of AP-2 in confining HIV-1 exit to distinct microdomains. Further, particle release from AP-2-mutant cells was enhanced compared to release from wild-type cells but the infectivity of virus released from these cells was moderately reduced. Together these data attribute a role to the AP-2 complex in the regulation of HIV-1 assembly/release.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16139856     DOI: 10.1016/j.virol.2005.08.001

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  54 in total

Review 1.  HIV-1 assembly, budding, and maturation.

Authors:  Wesley I Sundquist; Hans-Georg Kräusslich
Journal:  Cold Spring Harb Perspect Med       Date:  2012-07       Impact factor: 6.915

Review 2.  Properties and functions of the nucleocapsid protein in virus assembly.

Authors:  Delphine Muriaux; Jean-Luc Darlix
Journal:  RNA Biol       Date:  2010-11-01       Impact factor: 4.652

3.  Human immunodeficiency virus type 1 and related primate lentiviruses engage clathrin through Gag-Pol or Gag.

Authors:  Sergei Popov; Bettina Strack; Victor Sanchez-Merino; Elena Popova; Heike Rosin; Heinrich G Göttlinger
Journal:  J Virol       Date:  2011-02-02       Impact factor: 5.103

4.  Analysis of human immunodeficiency virus matrix domain replacements.

Authors:  Isabel Scholz; Amelia Still; Tenzin Choesang Dhenub; Kelsey Coday; Mike Webb; Eric Barklis
Journal:  Virology       Date:  2007-11-08       Impact factor: 3.616

5.  The clathrin adaptor complex AP-1 binds HIV-1 and MLV Gag and facilitates their budding.

Authors:  Grégory Camus; Carolina Segura-Morales; Dorothee Molle; Sandra Lopez-Vergès; Christina Begon-Pescia; Chantal Cazevieille; Peter Schu; Edouard Bertrand; Clarisse Berlioz-Torrent; Eugenia Basyuk
Journal:  Mol Biol Cell       Date:  2007-05-30       Impact factor: 4.138

Review 6.  The non-canonical roles of clathrin and actin in pathogen internalization, egress and spread.

Authors:  Ashley C Humphries; Michael Way
Journal:  Nat Rev Microbiol       Date:  2013-08       Impact factor: 60.633

7.  Human Ubc9 contributes to production of fully infectious human immunodeficiency virus type 1 virions.

Authors:  Tareq Jaber; Christopher R Bohl; Gentry L Lewis; Charles Wood; John T West; Robert A Weldon
Journal:  J Virol       Date:  2009-07-29       Impact factor: 5.103

8.  Evidence of a role for soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) machinery in HIV-1 assembly and release.

Authors:  Anjali Joshi; Himanshu Garg; Sherimay D Ablan; Eric O Freed
Journal:  J Biol Chem       Date:  2011-06-16       Impact factor: 5.157

9.  Evidence that productive human immunodeficiency virus type 1 assembly can occur in an intracellular compartment.

Authors:  Anjali Joshi; Sherimay D Ablan; Ferri Soheilian; Kunio Nagashima; Eric O Freed
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

10.  Mutation of critical serine residues in HIV-1 matrix result in an envelope incorporation defect which can be rescued by truncation of the gp41 cytoplasmic tail.

Authors:  Ajay K Bhatia; Rajnish Kaushik; Nancy A Campbell; Suzanne E Pontow; Lee Ratner
Journal:  Virology       Date:  2008-12-06       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.